Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine versus propofol for sedation during aeromedical retrieval of acutely agitated psychiatric patients
ACTRN12616001134415Phase 4Terminated
- Sponsor
- CareFlight
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ketamine and propofol in suicidal ideation, major depressive disorder (MDD), acute psychosis and 4 more (2 arms), sponsored by CareFlight. Primary endpoints: Airway complications, Breathing complications and 2 more. Started Sep 2016; status: terminated.
02
Drugs
ketaminepropofol
03
Conditions
suicidal ideationmajor depressive disorder (MDD)acute psychosisschizophreniapostpartum depression (PPD)
Beyond the preview
Go deeper on ACTRN12616001134415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616001134415.